Clinician Consulting: Cannabinoid Therapy for Chronic Pain
Practical, protocol-driven guidance for clinicians ready to integrate cannabinoid therapeutics — confidently and responsibly.
Chronic pain patients are asking. Evidence is expanding. But most physicians lack a clear, practical framework for implementing cannabinoid therapy — from identifying appropriate candidates to managing titration and long-term outcomes.
Dr. Deondra Asike, MD, brings double board certification in anesthesiology and pain medicine, years of cannabis clinical practice, and direct experience advising at the state policy level to help you fill that gap.
What Physician Consulting Includes:
-
Candidate identification and patient screening frameworks
-
Initiation protocols and documentation guidance
-
Titration strategies and monitoring benchmarks
-
Long-term optimization and treatment plan refinement
-
Guidance on navigating state-specific regulations and certifying requirements
Whether you’re brand new to cannabinoid therapeutics or looking to sharpen an existing approach, consulting with Dr. Asike gives you actionable protocols grounded in clinical experience — not conjecture.
What Physician Consulting Includes:
-
You have patients who ask about cannabis but you don’t know where to start
-
You want to offer cannabinoid therapy but lack a systematic approach
-
You’ve begun certifying patients and need clinical mentorship to optimize outcomes
-
You want to ensure your practice is defensible, documented, and evidence-informed
Consulting arrangements are customized to your practice needs. To explore whether this is the right fit, [request a discovery call].
Service Format
Investment Discovery Call 20–30 min, Zoom or phone Complimentary
- Single Strategy Session 60 min
- Starter Package3 sessions, 60 min each
-
Monthly Retainer2–3 calls/month + async support
- Group/Practice Session Up to 5 clinicians, 90 min
Consulting arrangements are customized to your practice. I welcome the conversation.
Request a Discovery CallF.A.Q.s
Q 1: Is this covered by any professional development or CME budget?
A: Consulting sessions may qualify as professional development. We recommend checking with your practice administrator. CME-eligible programming is in development.
Q 2: Will you review my actual patient cases?
A: Yes, within appropriate privacy guidelines. Case-based consultation is one of the most common and valuable formats.
Q 3: I'm just starting to think about offering cannabinoid therapy. Is it too early to consult?
A: No — in fact, earlier is better. Building the right framework from the start saves significant time and prevents common clinical and documentation pitfalls.
Q 4: What states do you work with?
A: Dr. Asike is based in Maryland and has deep expertise in Maryland’s regulatory framework, but consults with clinicians across states with active medical cannabis programs.
Disclaimer: Clinician consulting services provided by National Pain ReLEAF represent clinical education and peer consultation. This does not establish a physician-patient relationship and does not constitute medical-legal advice.
